Premium
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?
Author(s) -
Bendtzen K.,
Steenholdt C.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13921
Subject(s) - medicine , adalimumab , antibody response , antibody , immunology , dermatology , tumor necrosis factor alpha
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom